All Omics Content

Bringing you the latest research in genomics and more through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Written Q&A
We sat down with the Co-director of Yale Genome Editing Centre of Yale University, Xiaojun Xing, to discuss his breakthrough cryopreservation method and his thoughts on the genome editing landscape.
17 March 2022
Genome Editing
Discussion Group Report
Our February Omics discussion group focused on novel genome editing and how new technologies are being used to tackle the challenges of transitioning to therapeutic use.
By Oliver Picken |
11 March 2022
Genome Editing
Video Content
Video Q&A
In Conversation With Mike Koob, Associate Professor in the Department of Laboratory Medicine and Pathology at the University of Minnesota
01 March 2022
Genome Editing
Video Content
Video Q&A
In Conversation With Gabor Balazsi, Henry Laufer Professor, Stony Brook University
02 February 2022
Genome Editing
Video Content
Webinar
Webinar hosted by Dr. Benjamin Schmid, Research Scientist, Cellular Engineering & Disease Models, Bioneer A/S & Peter Mouritzen, VP Application & market Development, Samplix ApS
10 June 2021
Genome Editing
Video Content
Video Q&A
Video Interview | Florian Baumgartner, Senior Product Manager Spatial Informatics at 10x Genomics
30 March 2021
Genome Editing
Video Content
Webinar
Presented by Dr Guillaume Pavlovic, Head of Unit - Genetic Engineering & Model Validation Department, PHENOMIN - ICS - IGBMC
29 October 2020
Genome Editing
Video Content
Webinar
Presented by Eric Paul Bennett, Associate Professor, Copenhagen University, Senior Advisor, NovoNordisk
18 September 2020
Genome Editing, NextGen Omics Series
Video Content
Webinar
Hosted by James Yen, Senior Scientific Manager, CDx Programs, NeoGenomics
23 July 2020
Genome Editing, NextGen Omics Series
Written Q&A
As pharmaceutical companies give more and more attention to genome editing technologies, the potential for CRISPR to play a role in drug discovery and development is beginning to be realised. We talked to Ricky Trigg from GlaxoSmithKline about the use of CRISPR for target screening
04 May 2020
Genome Editing, NextGen Omics Series

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login